The wearable device market continues to grow globally, with over 30% of individuals in North America owning a device, and over 95% owning a sensor-enabled smartphone. But what value are these devices bringing, and how will they impact health and wellness into the future? We believe that the value in wearables is all in the data. In particular, how the data is used to enable individuals and groups to better understand and manage their health, wellness and risks.
Never before have we had the ability to measure, monitor and motivate health in such a powerful way. The data to improve health is now in all of our pockets and on our wrists.
In this session, we will explore how innovative Canadian companies and researchers are turning wearable device data into actionable insights and real impacts to health, insurance and the economy. Our aim is to understand how this data can be used not only to explain what is happening in people's lives, but also to diagnose, predict and prevent disease.
This program is also available via webinar.
3:15pm - 3:30pm: Registration Opens, Networking & Introductions
3:30pm - 4:00pm: Presentation Webinar Begins
4:00pm - 5:00pm: Wearables Data Panel
5:00pm - 5:20pm: Audience Q&A
5:20pm - 6:00pm: Networking & Refreshments
Christy Lane, PhD - Visiting Associate Professor
Wearable Health Lab
Physical Medicine and Rehabilitation
Dr. Christy Lane, PhD is an award-winning exercise scientist with expertise in big data, wearable devices, and lifestyle medicine. Currently, she is a Visiting Associate Professor in Orthopaedics at Stanford University. She is also a founding member of the Stanford Wearable Health Lab and an Associate Professor of Health and Physical Education at Mount Royal University. Christy has won many international awards for her work in lifestyle medicine and the application of technology in health, and speaks often internationally on these topics. She was recently recognized as Top 40 Under 40 in Calgary and winner of the Female Founders of Insuretech Award for her work with Vivametrica.
Jane Wang - CEO
Jane is the CEO of Optimity, an InsurTech provider that offers a digital wellness engagement platform for insurers and employers that uses AI & gamification to support healthy living. The platform learns about the user through dynamic assessments and is able to educate and support them on healthy activities, financial best practices, and life style choices to hit their goals. Prior to Optimity, Jane worked in phase 2 & 3 global clinical trials in maximizing adherence and performing dynamic risk scoring using software for patients in North America, Asia and the EU, she is passionate about proactively improving morbidity & mortality, and innovative behaviour amplification programs using gamification.
Paul Rivard - 2nd VP Underwriting Client Solutions
Paul is currently 2nd VP Underwriting Client Solutions at Munich Re, where he works to execute high value solutions that connect with insurers’ strategies. His background and current work is focused on underwriting and risk selection in personal lines, and mainly Life Insurance. In addition to client solutions ranging from underwriting automation, predictive models and underwriting transformation projects, Paul is a “futurist”. He is constantly engaging with startup communities, healthcare and technology innovators, and applying this knowledge and insight to the insurance industry. Paul is convinced that our business will be transformed in the coming years, and is an advocate for industry experts and leaders to take charge, and set the destination and own the future.
Mark Gorelick, PhD - Co-Founder & Chief Product Officer
Mark is a Co-Founder and Chief Product Officer for Step Health. He is a senior leader offering extensive expertise as a health professional, biomedical specialist, product developer, researcher, and educator. A digital health thought leader with advanced industry knowledge in the clinical, educational, and private health sectors. Mark comes to Step Health from Performance Labs as VP Digital Health, where he developed a global product strategy to bridge the existing sports-performance business with a new health insurance target market. Previous to that he was the Chief Science Officer at PAI Health (formerly Mio Global), where he drove cutting edge sensing technology while managing R&D for the fitness and health markets.